Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults

March 12, 2024 updated by: Lee Lindquist, Northwestern University
This study seeks to better understand how older adult aging-in-place/long term care decision making and implementation is impacted by age-related changes (e.g. cognition, health literacy, chronic conditions), social influences (e.g. caregivers/supporters), and environmental factors.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Subjects who are part of the National Institute on Aging (NIA)-funded LitCog study will be given access to PlanYourLifespan.org, a web-based decision-making and planning tool. Participants will be followed for up to 42 months to examine the mediating/moderating factors involved in decision-making, timing of decision implementation, and goal concordance. Findings have the potential to inform healthcare providers, caregivers, health/long term care insurers, area agencies on aging, and older adults nationally in supporting aging-in-place decisions and services use.

Study Type

Interventional

Enrollment (Actual)

293

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Current participant in the LitCog Trial [R01AG03611]
  • English-speaking
  • Community-dwelling
  • Currently use a computer or tablet with internet

Exclusion Criteria:

  • Previous participation in the Advanced Planning for Home Services study [IH-12-11-4259]

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Access to Web-Based Intervention
All study participants will be given access to the web-based study intervention, PlanYourLifespan.org.
The study intervention is a web-based planning tool, PlanYourLifespan.org

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in long-term care plan decision-making
Time Frame: Change from baseline decision-making at 36 months. Will also be measured every six months, up to 42 months.
Change in participant's long-term care plan decision-making from baseline to 36 months post-baseline. Decision-making will be measured as a binary ('yes', 'no') outcome at each time-point.
Change from baseline decision-making at 36 months. Will also be measured every six months, up to 42 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant utilization of long-term care services
Time Frame: Baseline and every six months, up to 42 months
Participant utilization of long-term care services such as in-home caregivers as measured by the Resource Use Inventory (Sano M, Zhu CW, Whitehouse PJ, et al. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S191-S202. doi:10.1097/01.wad.0000213875.63171.87).
Baseline and every six months, up to 42 months
Number of participants that implement any of their long-term care plans
Time Frame: Baseline and every six months, up to 42 months
The number of participants that implement any long-term care plans they have set. This will be measured as a binary ('yes', 'no') outcome at each time-point.
Baseline and every six months, up to 42 months
Participant long-term care goal concordance
Time Frame: Baseline and every six months, up to 42 months
Assess whether participant's long-term care plans are carried out in accordance to their goals. This will be measured as a binary ('yes', 'no') outcome at each time-point.
Baseline and every six months, up to 42 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2020

Primary Completion (Estimated)

November 29, 2024

Study Completion (Estimated)

February 28, 2025

Study Registration Dates

First Submitted

May 16, 2019

First Submitted That Met QC Criteria

May 20, 2019

First Posted (Actual)

May 23, 2019

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • R01AG058777 (U.S. NIH Grant/Contract)
  • 1R01AG058777-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

3
Subscribe